Crispr Therapeutics Ag (CRSP)

Free Cash Flow

-$86.62M

Quarterly · Period ending: · USD

CRSP logo

CRSP Free Cash Flow

Latest reported-$86.62M
CRSP Quarterly Free Cash Flow (-$1.58M → -$86.62M)
High-resolution chart · PNG

CRSP free cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Free Cash Flow — Quarterly (USD)
Period endingFree Cash Flow (USD)
-86,619,000
-109,401,000
-93,070,000
-84,708,000
-113,997,000
-54,153,000
-50,285,000
-107,132,000
-96,289,000
109,031,000
-96,811,000
-41,974,000
-136,800,000
5,740,000
-119,519,000
-111,235,000
-151,586,000
-150,589,000
-95,221,000
-118,378,000
778,553,000
-107,687,000
-87,451,000
-81,223,000
-32,884,000
-55,166,000
2,424,000
130,959,000
-38,556,000
-44,834,000
-29,372,000
-20,659,000
-25,738,000
-23,243,000
-15,047,000
-18,862,000
-17,305,000
-26,697,000
-19,644,000
-13,785,000
-14,651,000
-10,246,000
68,501,000
-5,862,000
-2,782,000
-1,583,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.